Lovastatin and Breastfeeding

Since no human studies have been performed on breastfeeding and lovastatin, it is not known whether the drug passes through breast milk. There are theoretical risks to a nursing infant, however, so it is generally recommended that you wait until you have weaned your child before starting treatment. Breastfeeding women should consult their healthcare provider to further discuss the risks.

Breastfeeding and Lovastatin: An Overview

At this time, it is unknown if lovastatin (Mevacor®) passes through breast milk in humans. Because of the theoretical risks to the nursing child, the manufacturer recommends that breastfeeding women avoid taking it. Therefore, you should talk with your healthcare provider before taking lovastatin if you are breastfeeding or plan to start.
 

Can I Take Lovastatin While Breastfeeding?

It is not clear if lovastatin would cause significant problems in a breastfed infant. The effects of high cholesterol do not cause problems for many years or even decades. Therefore, if a woman does not take lovastatin or other cholesterol medications during breastfeeding, it will likely have only a minimal impact on her long-term risks. Therefore, it is best to wait until you have weaned your child before starting lovastatin.
 

Talking With Your Healthcare Provider

You should talk with your healthcare provider about lovastatin and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
 
Baby Milestones You've Never Heard Of
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.